Central Nervous System Neoplasms
-
Subject Areas on Research
-
18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients.
-
A genetically modified allogeneic cellular vaccine generates MHC class I-restricted cytotoxic responses against tumor-associated antigens and protects against CNS tumors in vivo.
-
A phase 1 study of PF-06840003, an oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor in patients with recurrent malignant glioma.
-
A phase I study of panobinostat in pediatric patients with refractory solid tumors, including CNS tumors.
-
A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma.
-
Activity of 9-dimethylaminomethyl-10-hydroxycamptothecin against pediatric and adult central nervous system tumor xenografts.
-
Activity of temozolomide in the treatment of central nervous system tumor xenografts.
-
Adrenal relapse of primary central nervous system diffuse large B-cell lymphoma: A case report.
-
Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT.
-
Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011.
-
Altered telomeres in tumors with ATRX and DAXX mutations.
-
American Brain Tumor Association Adolescent and Young Adult Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.
-
An unusual presentation of chronic myelogenous leukemia: a review of isolated central nervous system relapse.
-
Analysis of 60 reported glioma risk SNPs replicates published GWAS findings but fails to replicate associations from published candidate-gene studies.
-
Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201.
-
B-Cell Depletion Reduces the Maturation of Cerebral Cavernous Malformations in Murine Models.
-
Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors.
-
Brain and other central nervous system tumor statistics, 2021.
-
Breast cancer following spinal irradiation for a childhood cancer: A report from the Childhood Cancer Survivor Study.
-
CBTRUS Statistical Report: Pediatric Brain Tumor Foundation Childhood and Adolescent Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018.
-
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.
-
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013.
-
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015.
-
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.
-
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017.
-
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018.
-
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015-2019.
-
CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010.
-
CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.
-
Cancer in pregnancy: a review of the literature. Part I.
-
Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII.
-
Cellular mechanisms of cyclophosphamide resistance: model studies in human medulloblastoma cell lines.
-
Central Nervous System Cancers, Version 1.2015.
-
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
-
Central Nervous System Tumor Classification: An Update on the Integration of Tumor Genetics.
-
Central Nervous System Tumors in Uganda: Outcomes of Surgical Treatment and Complications Assessed Through Telephone Survey.
-
Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines.
-
Central nervous system cancers.
-
Central nervous system cancers.
-
Central nervous system cancers.
-
Central nervous system cancers: Clinical Practice Guidelines in Oncology.
-
Central nervous system involvement by cutaneous T cell lymphoma.
-
Central nervous system manifestations of marginal zone B-cell lymphoma.
-
Central nervous system tumor distribution at a tertiary referral center in Uganda.
-
Central nervous system.
-
Changes in survival over time for primary brain and other CNS tumors in the United States, 2004-2017.
-
Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial.
-
Clinical and Genetic Risk Prediction of Subsequent CNS Tumors in Survivors of Childhood Cancer: A Report From the COG ALTE03N1 Study.
-
Comparative integrated molecular analysis of intraocular medulloepitheliomas and central nervous system embryonal tumors with multilayered rosettes confirms that they are distinct nosologic entities.
-
Completeness and concordancy of WHO grade assignment for brain and central nervous system tumors in the United States, 2004-2011.
-
Completeness of required site-specific factors for brain and CNS tumors in the Surveillance, Epidemiology and End Results (SEER) 18 database (2004-2012, varying).
-
Conditional survival after diagnosis with malignant brain and central nervous system tumor in the United States, 1995-2012.
-
Conformal radiation therapy for childhood CNS tumors.
-
Cyclophosphamide, doxorubicin, vincristine, and prednisone for primary central nervous system lymphoma: short-duration response and multifocal intracerebral recurrence preceding radiotherapy.
-
Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015.
-
Detection of glioma-associated gangliosides GM2, GD2, GD3, 3'-isoLM1 3',6'-isoLD1 in central nervous system tumors in vitro and in vivo using epitope-defined monoclonal antibodies.
-
Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study.
-
Do race and age vary in non-malignant central nervous system tumor incidences in the United States?
-
Dose intensive melphalan and cyclophosphamide with autologous hematopoietic stem cells for recurrent medulloblastoma or germinoma.
-
Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study.
-
Embryonal central nervous system neoplasms arising in infants and young children: a pediatric brain tumor consortium study.
-
Epidemiology of Brain and Other CNS Tumors.
-
Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations.
-
Exomic sequencing of four rare central nervous system tumor types.
-
Germline genetic landscape of pediatric central nervous system tumors.
-
Glioblastoma multiforme: a review of where we have been and where we are going.
-
Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy.
-
Gliomatosis cerebri: cytologic and autopsy findings in a case involving the entire neuraxis.
-
Glioneuronal tumors of the central nervous system.
-
Global incidence of malignant brain and other central nervous system tumors by histology, 2003-2007.
-
Global, regional, and national burden of brain and other CNS cancer, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
-
HIV disorders of the brain: pathology and pathogenesis.
-
Hematologic toxicity during craniospinal irradiation: the impact of prior chemotherapy.
-
High-dose methotrexate for primary CNS lymphoma in the elderly.
-
High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma.
-
Immunohistochemistry of the glial fibrillary acidic protein: basic and applied considerations.
-
Importance of the intersection of age and sex to understand variation in incidence and survival for primary malignant gliomas.
-
Improved grading of IDH-mutated astrocytic gliomas.
-
Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013.
-
Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202).
-
Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251.
-
Intracerebral Flexner-Wintersteiner Rosette-Rich Tumor With Somatic RB1 Mutation: A CNS Embryonal Tumor With Retinoblastic Differentiation.
-
Invasiveness is associated with metastasis and decreased survival in hemangiopericytoma of the central nervous system.
-
Irinotecan treatment for recurrent malignant glioma using an every-3-week regimen.
-
Is There a Role for Immunotherapy in Central Nervous System Cancers?
-
Is mortality due to primary malignant brain and other central nervous system tumors decreasing?
-
Isolated Central Nervous System Chloroma as a Presenting Sign of Relapsed Pediatric Acute Lymphoblastic Leukemia.
-
Lactotetraose series ganglioside 3',6'-isoLD1 in tumors of central nervous and other systems in vitro and in vivo.
-
Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis.
-
Longitudinal assessment of late-onset neurologic conditions in survivors of childhood central nervous system tumors: a Childhood Cancer Survivor Study report.
-
Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation.
-
Molecular phenotype of simian virus 40 large T antigen-induced primitive neuroectodermal tumors in four different lines of transgenic mice.
-
Mutant metabolic enzymes are at the origin of gliomas.
-
NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017.
-
No free lunch: secondary neoplasms after stereotactic radiation.
-
Noncutaneous malignant tumors in the PUVA follow-up study: 1975-1996.
-
O6-benzylguanine-mediated enhancement of chemotherapy.
-
O6-benzylguanine-mediated enhancement of nitrosourea activity in Mer- central nervous system tumor xenografts--implications for clinical trials.
-
O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma.
-
PROMACE-MOPP and intrathecal chemotherapy for CNS lymphomas.
-
Pan-PI3Ki targets multiple B-ALL microenvironment interactions that fuel systemic and CNS relapse.
-
Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECT.
-
Patterns of relapse after successful completion of initial therapy in primary central nervous system lymphoma: a case series.
-
Pediatric Central Nervous System Tumors in Nepal: Retrospective Analysis and Literature Review of Low- and Middle-Income Countries.
-
Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.
-
Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma.
-
Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors.
-
Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma.
-
Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma.
-
Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas.
-
Phase III clinical evaluation of gadoteridol injection: experience in pediatric neuro-oncologic MR imaging.
-
Pigmented Lesions of the Nervous System and the Neural Crest: Lessons From Embryology.
-
Pilocytic astrocytoma: correlation between the initial imaging features and clinical aggressiveness.
-
Pilocytic astrocytomas: where do they belong in cancer reporting?
-
Preparing an oncolytic poliovirus recombinant for clinical application against glioblastoma multiforme.
-
Primary CNS lymphoma in HIV positive and negative patients: comparison of clinical characteristics, outcome and prognostic factors.
-
Primary central nervous system histiocytic sarcoma: A case report and review of literature.
-
Primary central nervous system lymphoma in patients with and without HIV infection: a multicenter study and comparison with U.S national data.
-
Primary central nervous system lymphoma with systemic metastasis: case report and review.
-
Primary central nervous system lymphomas: a 30-year experience at a single institution.
-
Promising survival and concomitant radiation plus temozolomide followed by adjuvant temozolomide.
-
Recent advances in the treatment of malignant astrocytoma.
-
Reply to M.C. Chamberlain.
-
Risk assessment for developing gliomas: a comparison of two cytogenetic approaches.
-
SEER insights.
-
Safety and Diagnostic Efficacy of Gadobenate Dimeglumine in MRI of the Brain and Spine of Neonates and Infants.
-
Second messenger systems in human gliomas.
-
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.
-
Single nucleotide polymorphisms of matrix metallopeptidase 3 and risk of gliomas in a Chinese Han population.
-
Surgical neuropathology update: a review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition.
-
Surveillance for subsequent neoplasms of the CNS for childhood, adolescent, and young adult cancer survivors: a systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
-
Survivorship in adults with malignant brain and other central nervous system tumor from 2000-2014.
-
Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma.
-
Template for Reporting Results of Biomarker Testing of Specimens From Patients With Tumors of the Central Nervous System.
-
The CBTRUS story: providing accurate population-based statistics on brain and other central nervous system tumors for everyone.
-
The Epidemiology of Central Nervous System Tumors.
-
The Utility of Expert Diagnosis in Surgical Neuropathology: Analysis of Consultations Reviewed at 5 National Comprehensive Cancer Network Institutions.
-
The current landscape of immunotherapy for pediatric brain tumors.
-
The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades.
-
The potential of cerebrospinal fluid-based liquid biopsy approaches in CNS tumors.
-
Topotecan for the treatment of recurrent or progressive central nervous system tumors - a pediatric oncology group phase II study.
-
Transcriptome clarifies mechanisms of lesion genesis versus progression in models of Ccm3 cerebral cavernous malformations.
-
Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA.
-
Treatment of newly diagnosed glioblastoma multiforme.
-
Trends in central nervous system tumor incidence relative to other common cancers in adults, adolescents, and children in the United States, 2000 to 2010.
-
Understanding the Revised Fourth Edition of the World Health Organization Classification of Tumours of the Central Nervous System (2016) for Clinical Decision-making: A Guide for Oncologists Managing Patients with Glioma.
-
Utility of postmortem magnetic resonance imaging in clinical neuropathology.
-
Viruses as therapeutic agents against malignant disease of the central nervous system.
-
Viruses for the treatment of malignant glioma.
-
Years of potential life lost for brain and CNS tumors relative to other cancers in adults in the United States, 2010.
-
ZD6474, a novel tyrosine kinase inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor, inhibits tumor growth of multiple nervous system tumors.
-
Keywords of People
-
McLendon, Roger Edwin,
Professor of Pathology,
Pathology
-
Sampson, John Howard,
Robert H., M.D. and Gloria Wilkins Professor of Neurosurgery, in the School of Medicine,
Biomedical Engineering
-
Yan, Hai,
Adjunct Professor of Pathology,
Pathology